High Cholesterol Blood Test: LDL, HDL, Triglycerides, Normal Range & Lipid Profile Interpretation (2026)
Last Updated: August 20, 2026
A lipid profile, also called a lipid panel, is one of the most commonly requested laboratory tests for evaluating cardiovascular risk. It measures several circulating lipids and lipoprotein-related parameters, most commonly total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.
High cholesterol is clinically important because elevated concentrations of atherogenic lipoproteins, particularly LDL-containing particles, are strongly associated with atherosclerotic cardiovascular disease. However, interpretation should never depend on a single laboratory number. Age, diabetes, smoking, blood pressure, kidney disease, family history, previous cardiovascular disease, medications, diet, and the patient's overall risk profile must also be considered.
For laboratory professionals, lipid testing also involves important analytical questions: Was the specimen fasting or nonfasting? Was LDL measured directly or calculated? Are triglycerides high enough to affect LDL calculation? Was the sample collected and processed correctly? Are quality-control results acceptable? Could paraproteins, severe lipemia, hemolysis, or other interferences affect the result?
Quick Laboratory Summary:
- Total cholesterol represents cholesterol carried in several lipoprotein fractions.
- LDL-C is one of the most important atherogenic lipid measurements.
- HDL-C is traditionally called “good cholesterol,” but cardiovascular risk assessment is more complex than simply aiming for the highest possible HDL value.
- Triglycerides are circulating fats influenced by diet, metabolism, alcohol, diabetes, medications, and genetic factors.
- Non-HDL cholesterol equals total cholesterol minus HDL cholesterol.
- Calculated LDL may become unreliable in certain situations, particularly with markedly elevated triglycerides.
- Reference intervals and treatment targets are not identical concepts.
- Always interpret results according to the reporting laboratory, clinical context, and current cardiovascular guidelines.
1. What Is Cholesterol?
Cholesterol is a waxy lipid that is essential for normal human physiology. It is incorporated into cellular membranes and serves as a precursor for steroid hormones, bile acids, and vitamin D synthesis.
Because cholesterol is poorly soluble in plasma, it is transported through the circulation within lipoprotein particles. These particles contain different combinations of cholesterol, triglycerides, phospholipids, and apolipoproteins.
The major lipoprotein classes include:
- Chylomicrons
- Very-low-density lipoprotein (VLDL)
- Intermediate-density lipoprotein (IDL)
- Low-density lipoprotein (LDL)
- High-density lipoprotein (HDL)
The clinical significance of cholesterol therefore depends not only on the total amount of cholesterol in plasma but also on the lipoprotein particles carrying it.
2. What Is a Lipid Profile?
A lipid profile is a group of blood tests used to assess circulating lipids and help estimate cardiovascular risk.
A routine lipid profile usually includes:
- Total cholesterol
- LDL cholesterol
- HDL cholesterol
- Triglycerides
Some laboratory reports may additionally provide:
- Non-HDL cholesterol
- VLDL cholesterol
- Total cholesterol/HDL ratio
- LDL/HDL ratio
Additional cardiovascular risk tests may include apolipoprotein B, apolipoprotein A-I, and lipoprotein(a).
3. Components of a Lipid Panel
| Test Main Meaning General Clinical Importance | ||
|---|---|---|
| Total Cholesterol | Total cholesterol in circulating lipoproteins | Broad screening parameter |
| LDL-C | Cholesterol associated primarily with LDL particles | Major atherogenic cholesterol measurement |
| HDL-C | Cholesterol carried in HDL particles | Part of cardiovascular risk assessment |
| Triglycerides | Major circulating storage form of fatty acids | Relevant to metabolic and cardiovascular assessment |
| Non-HDL-C | Total cholesterol minus HDL-C | Represents cholesterol in atherogenic particles |
4. Normal and Desirable Lipid Levels
For most adults, commonly used general reference categories include the values below. These values should be interpreted cautiously because clinical treatment goals may be lower for patients with established cardiovascular disease or other high-risk conditions.
| Parameter General Desirable Level | |
|---|---|
| Total Cholesterol | <200 mg/dL |
| LDL Cholesterol | <100 mg/dL generally considered desirable |
| Non-HDL Cholesterol | <130 mg/dL generally desirable in many adults |
| Triglycerides | <150 mg/dL |
| HDL Cholesterol | Higher values are generally associated with lower risk; ≥60 mg/dL has traditionally been considered favorable |
Important: These values are general educational categories, not universal treatment targets. A patient's optimal LDL-C may need to be substantially lower depending on cardiovascular risk.
Conversion Between mg/dL and mmol/L
For cholesterol:
mg/dL × 0.02586 = mmol/L
For triglycerides:
mg/dL × 0.01129 = mmol/L
5. Total Cholesterol
Total cholesterol measures cholesterol contained in multiple circulating lipoprotein fractions.
It provides useful screening information but cannot identify which lipoprotein component is responsible for an abnormal result.
For example, two patients with identical total cholesterol concentrations may have very different LDL, HDL, triglyceride, and non-HDL patterns.
Laboratory Pearl: Never interpret total cholesterol without reviewing LDL-C, HDL-C, triglycerides, and the patient's cardiovascular risk factors.
6. LDL Cholesterol
LDL particles transport cholesterol from the liver to peripheral tissues. Persistently elevated concentrations of LDL-containing atherogenic particles promote cholesterol deposition within arterial walls and contribute to atherosclerotic plaque development.
This is why LDL cholesterol remains one of the most important laboratory markers in cardiovascular risk assessment and lipid-lowering therapy.
| LDL-C Common Descriptive Category | |
|---|---|
| <100 mg/dL | Optimal or desirable for many adults |
| 100–129 mg/dL | Near optimal |
| 130–159 mg/dL | Borderline high |
| 160–189 mg/dL | High |
| ≥190 mg/dL | Very high; familial or secondary causes should be considered |
These descriptive categories are useful educationally but should not be confused with individualized treatment goals.
7. HDL Cholesterol
HDL participates in reverse cholesterol transport and several other metabolic processes. Higher HDL-C concentrations have historically been associated epidemiologically with lower cardiovascular risk.
However, HDL biology is complex. HDL-C concentration does not directly measure HDL particle function, and extremely high HDL-C is not necessarily protective in every clinical situation.
For routine laboratory interpretation, HDL-C remains a component of established cardiovascular risk calculations and is also used to calculate non-HDL cholesterol.
8. Triglycerides
Triglycerides are the major circulating form of stored fatty acids. They are transported predominantly in chylomicrons after meals and in VLDL particles produced by the liver.
| Triglyceride Level General Interpretation | |
|---|---|
| <150 mg/dL | Normal |
| 150–199 mg/dL | Borderline high |
| 200–499 mg/dL | High |
| ≥500 mg/dL | Severe hypertriglyceridemia; pancreatitis risk becomes clinically important |
Very high triglycerides may occur in uncontrolled diabetes, excessive alcohol consumption, obesity, hypothyroidism, genetic disorders, renal disease, and with certain medications.
9. Non-HDL Cholesterol
Non-HDL cholesterol is calculated as:
Non-HDL-C = Total Cholesterol − HDL-C
It represents cholesterol carried by potentially atherogenic apolipoprotein B-containing particles, including LDL, IDL, VLDL remnants, and lipoprotein(a).
An advantage of non-HDL cholesterol is that it does not require a separate analytical measurement and remains useful when triglycerides are elevated.
10. VLDL Cholesterol
VLDL particles are produced by the liver and primarily transport endogenous triglycerides.
VLDL cholesterol is often estimated rather than directly measured in routine laboratory practice. A commonly used approximation in fasting specimens is:
VLDL-C ≈ Triglycerides ÷ 5
when results are expressed in mg/dL.
This approximation becomes less reliable as triglyceride concentrations rise.
11. Fasting vs Nonfasting Lipid Testing
Historically, patients were routinely instructed to fast before a lipid panel. Contemporary practice increasingly accepts nonfasting lipid testing for many routine cardiovascular assessments.
Nonfasting testing is often adequate for:
- Routine cardiovascular screening
- Follow-up of many patients receiving lipid-lowering therapy
- Initial risk assessment
A fasting specimen may be particularly useful when:
- Triglycerides are significantly elevated
- A previous nonfasting triglyceride result is unexpectedly high
- Severe hypertriglyceridemia is suspected
- A calculation or laboratory method has specific fasting requirements
- The clinician is evaluating selected inherited lipid disorders
Important: Follow the collection instructions specified by the requesting clinician and the laboratory performing the test.
12. Causes of High Cholesterol
High cholesterol may result from genetic, metabolic, dietary, endocrine, renal, hepatic, or medication-related factors.
Common causes include:
- Genetic hypercholesterolemia
- Diet high in saturated fat
- Obesity
- Physical inactivity
- Diabetes mellitus
- Hypothyroidism
- Chronic kidney disease
- Nephrotic syndrome
- Cholestatic liver disease
- Some medications
- Age-related metabolic changes
13. Causes of High LDL Cholesterol
An increased LDL-C concentration may reflect either primary genetic hypercholesterolemia or a secondary medical cause.
Primary Causes
- Familial hypercholesterolemia
- Polygenic hypercholesterolemia
- Other inherited lipid disorders
Secondary Causes
- Hypothyroidism
- Nephrotic syndrome
- Chronic kidney disease
- Cholestasis
- Dietary excess of saturated fats
- Obesity and insulin resistance
- Selected medications
When LDL is markedly elevated, laboratory professionals should consider whether the result is persistent and whether previous lipid profiles show a similar pattern.
14. Causes of High Triglycerides
Hypertriglyceridemia has many possible causes, and more than one factor may be present in the same patient.
- Recent food intake
- Diabetes mellitus
- Obesity
- Metabolic syndrome
- Excessive alcohol intake
- Hypothyroidism
- Chronic kidney disease
- Pregnancy
- Genetic hypertriglyceridemia
- Certain medications
Markedly elevated triglycerides may produce visibly lipemic serum or plasma.
15. Low HDL Cholesterol
Low HDL-C is frequently associated with insulin resistance, obesity, smoking, hypertriglyceridemia, and physical inactivity.
Traditional descriptive thresholds commonly identify HDL-C below approximately 40 mg/dL in men and below approximately 50 mg/dL in women as low, although cardiovascular risk assessment should not depend on HDL-C alone.
Treatment decisions are generally focused more strongly on reducing atherogenic lipoprotein burden and overall cardiovascular risk than on pharmacologically attempting to increase HDL-C in isolation.
16. Familial Hypercholesterolemia
Familial hypercholesterolemia is an inherited disorder characterized by markedly increased LDL cholesterol and increased lifetime risk of premature atherosclerotic cardiovascular disease.
Features that may increase suspicion include:
- LDL-C ≥190 mg/dL in an adult
- Persistent marked LDL elevation
- Premature coronary disease
- Family history of premature cardiovascular disease
- Family members with very high LDL levels
- Tendon xanthomas in selected patients
The laboratory result is an important clue but does not by itself establish the diagnosis.
17. Diabetes and Lipid Profile
Related laboratory guide: HbA1c Blood Test: Normal Range, Prediabetes, Diabetes & Laboratory Interpretation.
Insulin resistance and type 2 diabetes may produce a characteristic dyslipidemic pattern consisting of:
- Elevated triglycerides
- Low HDL-C
- Increased numbers of atherogenic particles
- LDL-C that may appear only mildly elevated despite increased cardiovascular risk
Patients with diabetes therefore require cardiovascular risk assessment beyond total cholesterol alone.
18. Thyroid Disease and Lipids
Hypothyroidism is an important secondary cause of elevated LDL cholesterol because reduced thyroid hormone activity decreases hepatic LDL receptor activity and slows LDL clearance.
When unexplained dyslipidemia is present, thyroid function testing may be clinically appropriate.
Related reading: Thyroid Function Tests (TSH, FT3, FT4): Complete Laboratory Guide.
19. Kidney Disease and Lipids
Related laboratory guide: High Creatinine Levels: Causes, eGFR, BUN & Kidney Function.
Kidney disorders can significantly affect lipid metabolism. Nephrotic syndrome may produce marked hypercholesterolemia and increased LDL, while chronic kidney disease may be associated with hypertriglyceridemia and altered lipoprotein composition.
Kidney function, proteinuria, and the clinical context should therefore be reviewed when dyslipidemia is unexplained.
20. Liver Disease and Lipids
Related laboratory guides: Liver Function Tests (LFTs) and High Liver Enzymes (ALT & AST).
The liver plays a central role in cholesterol synthesis, triglyceride metabolism, lipoprotein production, and lipoprotein clearance.
Lipid abnormalities may occur with:
- Metabolic dysfunction-associated steatotic liver disease
- Cholestatic disease
- Alcohol-related liver disease
- Advanced hepatic dysfunction
Elevated ferritin may also accompany metabolic liver disease and should be interpreted in context. See: High Ferritin Levels: Causes and Laboratory Interpretation.
21. Calculated LDL and the Friedewald Equation
LDL cholesterol is frequently calculated rather than directly measured.
The classic Friedewald equation in mg/dL is:
LDL-C = Total Cholesterol − HDL-C − (Triglycerides ÷ 5)
The equation estimates VLDL cholesterol as triglycerides divided by 5.
Example
Total cholesterol = 220 mg/dL HDL-C = 50 mg/dL Triglycerides = 150 mg/dL
Estimated VLDL-C = 150 ÷ 5 = 30 mg/dL
Calculated LDL-C = 220 − 50 − 30 = 140 mg/dL
Laboratory Limitation: The Friedewald calculation becomes unreliable with markedly elevated triglycerides and should not be used outside the validated conditions of the laboratory.
More recent LDL estimation equations are available and may provide improved accuracy in selected triglyceride and LDL ranges. Laboratories should use equations validated for their patient population, information system, and reporting procedure.
22. Direct LDL Measurement
Direct LDL assays measure LDL cholesterol using reagent systems designed to selectively quantify cholesterol within LDL particles.
Direct LDL may be used when calculated LDL is considered unreliable or when laboratory protocols specify direct measurement.
However, direct methods are also method-dependent and are not completely free from analytical limitations.
23. Apolipoprotein B
Apolipoprotein B is the major structural apolipoprotein present in atherogenic particles including VLDL, IDL, LDL, and lipoprotein(a).
Because each atherogenic particle generally contains one ApoB molecule, ApoB concentration can provide information about the number of atherogenic particles rather than only the amount of cholesterol within those particles.
ApoB may be particularly informative when LDL-C and particle number are discordant, such as in some patients with:
- Diabetes
- Metabolic syndrome
- Elevated triglycerides
- Obesity
24. Lipoprotein(a)
Lipoprotein(a), abbreviated Lp(a), is an LDL-like particle containing apolipoprotein B linked to apolipoprotein(a).
Lp(a) concentration is predominantly genetically determined and is recognized as an independent cardiovascular risk factor.
Lp(a) should not be confused with LDL cholesterol, and its concentration cannot be reliably predicted from a standard lipid panel.
25. Specimen Requirements
Serum or plasma is commonly used for lipid testing depending on the analytical platform.
Laboratory procedures should specify:
- Accepted collection tube
- Minimum sample volume
- Fasting requirements, if applicable
- Storage conditions
- Sample stability
- Centrifugation requirements
- Criteria for rejecting unsuitable specimens
Patient identification and specimen labeling must be verified before analysis.
26. Preanalytical Factors Affecting Lipid Results
Related preanalytical guide: Hemolysis in Clinical Chemistry.
Preanalytical variation can significantly influence triglycerides and other lipid measurements.
Recent Food Intake
Triglycerides may rise after meals. The magnitude varies according to the meal and the individual patient's metabolism.
Alcohol
Recent alcohol consumption may increase triglycerides, particularly in susceptible individuals.
Acute Illness
Acute inflammatory or severe systemic illness may temporarily alter lipid concentrations. Results obtained during acute illness may not represent the patient's stable baseline.
Pregnancy
Physiological lipid concentrations may increase during pregnancy.
Posture and Hydration
Changes in plasma volume can produce modest differences in measured concentrations.
Medication Effects
Several medications can influence cholesterol and triglyceride concentrations. Medication history should therefore be considered during interpretation.
27. Laboratory Methods for Lipid Testing
Total Cholesterol
Automated clinical chemistry analyzers commonly use enzymatic colorimetric methods involving cholesterol ester hydrolysis, cholesterol oxidation, and production of a measurable chromogenic reaction.
Triglycerides
Triglycerides are commonly quantified enzymatically after hydrolysis to glycerol and fatty acids, followed by reactions that ultimately generate a measurable chromophore.
HDL Cholesterol
Modern analyzers frequently use homogeneous direct assays that selectively measure HDL cholesterol without requiring manual precipitation.
LDL Cholesterol
LDL may be:
- Calculated from the lipid profile
- Measured by direct homogeneous assays
Laboratory professionals must know which method is used because this affects interpretation, validation, and troubleshooting.
28. Analytical Interferences
Potential analytical interferences vary according to instrument and reagent manufacturer.
Important considerations include:
- Lipemia
- Hemolysis
- Icterus
- Paraproteinemia
- Extremely high triglycerides
- Reagent deterioration
- Calibration error
- Sample contamination
- Carryover
Interference limits must always be assessed according to manufacturer documentation and local verification studies rather than assumed from generic values.
29. Quality Control in Lipid Testing
Related quality guides: Internal Quality Control (IQC): Westgard Rules & Levey–Jennings Charts and Laboratory Quality Indicators (QIs): KPIs & ISO 15189.
Internal quality control is essential before patient results are released.
Quality-control procedures should monitor analytical performance at clinically relevant concentrations.
Laboratory staff should review:
- Control results
- Levey-Jennings charts
- Established QC rules
- Shifts and trends
- Calibration status
- Reagent lot changes
- Maintenance history
- Analyzer flags
If QC is unacceptable: Do not release potentially affected patient results. Investigate the cause, correct the analytical problem, restore acceptable QC performance, evaluate potentially affected patient samples, document corrective action, and only then resume routine reporting.
Possible Causes of Lipid QC Failure
- Deteriorated control material
- Incorrect control preparation
- Expired reagent
- Reagent instability
- Calibration failure
- Pipetting problem
- Temperature instability
- Analyzer malfunction
- Incorrect lot data
30. Practical Laboratory Interpretation Algorithm
- Confirm patient identification and specimen integrity.
- Check whether the specimen was fasting or nonfasting if clinically relevant.
- Review total cholesterol, LDL-C, HDL-C, and triglycerides together.
- Confirm whether LDL is calculated or directly measured.
- Evaluate triglyceride concentration before accepting calculated LDL.
- Calculate or review non-HDL cholesterol when appropriate.
- Compare results with the laboratory's reporting intervals and clinical decision limits.
- Review previous results for persistent abnormalities or major changes.
- Consider secondary causes such as diabetes, thyroid disease, kidney disease, liver disease, medications, and alcohol use.
- Consider familial hypercholesterolemia when LDL elevation is marked and persistent.
- Review QC and analytical flags before result validation.
- Correlate results with the patient's overall cardiovascular risk.
31. Clinical and Laboratory Case Studies
Case 1: Isolated High LDL
A 42-year-old patient has:
- Total cholesterol: 265 mg/dL
- LDL-C: 190 mg/dL
- HDL-C: 50 mg/dL
- Triglycerides: 125 mg/dL
Interpretation: LDL cholesterol is markedly elevated. Persistent LDL-C around or above 190 mg/dL should prompt consideration of severe primary hypercholesterolemia, including familial hypercholesterolemia, while secondary causes should also be excluded.
Case 2: High Triglycerides with Diabetes
A patient with poorly controlled diabetes has:
- Total cholesterol: 240 mg/dL
- HDL-C: 34 mg/dL
- Triglycerides: 420 mg/dL
Interpretation: This pattern is compatible with significant hypertriglyceridemia associated with insulin resistance or diabetes. Calculated LDL should be interpreted cautiously because triglyceride elevation may reduce calculation accuracy.
Case 3: Severe Hypertriglyceridemia
A visibly lipemic sample produces a triglyceride concentration of 870 mg/dL.
Interpretation: Severe hypertriglyceridemia is present. Calculated LDL using the traditional Friedewald equation is inappropriate. The result requires prompt clinical correlation because very high triglycerides increase the risk of acute pancreatitis.
Case 4: High Cholesterol with Hypothyroidism
A patient has persistent LDL elevation together with an elevated TSH.
Interpretation: Hypothyroidism is a recognized secondary cause of hypercholesterolemia. Lipid interpretation should therefore consider thyroid status.
Related article: Thyroid Function Tests: TSH, FT3 and FT4.
Case 5: High Cholesterol and High Ferritin
A patient with obesity and metabolic risk factors has elevated triglycerides, LDL-C, liver enzymes, and serum ferritin.
Interpretation: The pattern may occur with metabolic dysfunction and liver disease. Elevated ferritin does not automatically indicate iron overload.
Related article: High Ferritin Levels: Laboratory Interpretation and Differential Diagnosis.
Case 6: Cardiovascular Inflammation
A clinically stable patient undergoing cardiovascular risk assessment has dyslipidemia and elevated hs-CRP.
Interpretation: The lipid profile and hs-CRP provide different information. Lipids assess lipoprotein-related risk, while hs-CRP may provide information about low-grade systemic inflammation in selected cardiovascular risk-assessment contexts.
Related article: High CRP Levels and hs-CRP: Laboratory Interpretation.
Case 7: QC Failure Before Patient Release
LDL control results exceed the laboratory's acceptable range during a patient run.
Laboratory action: Patient results should not be released until the QC failure has been investigated and acceptable analytical performance restored. Review calibration, reagents, control material, analyzer status, maintenance, and potential procedural errors.
32. High Cholesterol and Cardiovascular Biomarkers
Related cardiac guide: High Troponin Levels: Delta Change, False Positives & ACS vs Non-ACS.
A lipid profile estimates long-term atherosclerotic risk, whereas cardiac biomarkers such as troponin are used in completely different clinical settings, particularly the assessment of myocardial injury.
An elevated LDL result therefore does not indicate that myocardial infarction is occurring.
For laboratory interpretation of cardiac markers, see: Cardiac Biomarkers: Troponin, CK-MB, Myoglobin and BNP.
33. High Cholesterol and Inflammation
Related inflammation guides: High CRP Levels: Causes, Normal Range & Clinical Interpretation and Erythrocyte Sedimentation Rate (ESR): Complete Laboratory Guide.
Atherosclerosis involves inflammatory biological processes, but routine cholesterol tests and inflammatory biomarkers are not interchangeable.
CRP may be elevated because of infection, autoimmune disease, trauma, surgery, obesity, or many other conditions.
See: High CRP Levels: Causes, Normal Range and Laboratory Interpretation.
34. High Cholesterol and Iron Metabolism
Related hematology guide: Complete Blood Count (CBC): Parameters, Interpretation & Clinical Significance.
Ferritin may be increased in metabolic disorders, inflammation, and liver disease, conditions that may coexist with dyslipidemia.
Ferritin should not be interpreted as a cardiovascular lipid marker.
For detailed interpretation: High Ferritin Levels: Causes, Iron Overload and Laboratory Interpretation.
35. Frequently Asked Questions
What is a lipid profile blood test?
A lipid profile is a blood test that usually measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. It is used as part of cardiovascular risk assessment.
What is considered high cholesterol?
Total cholesterol of 200 mg/dL or higher is commonly categorized as elevated, but cardiovascular risk depends more strongly on the complete lipid profile, particularly LDL cholesterol, and the patient's overall clinical risk.
What is a normal LDL level?
LDL-C below 100 mg/dL is generally considered desirable for many adults. Patients at high or very high cardiovascular risk may require substantially lower LDL targets.
Is LDL the bad cholesterol?
LDL is commonly called “bad cholesterol” because increased LDL-containing atherogenic particles contribute to cholesterol deposition in arterial walls and atherosclerosis.
Is HDL the good cholesterol?
HDL is traditionally called “good cholesterol” because higher HDL-C levels have been associated with lower cardiovascular risk. However, HDL biology is complex, and a high HDL result does not guarantee protection from cardiovascular disease.
What triglyceride level is considered high?
Triglycerides from 150–199 mg/dL are commonly categorized as borderline high, 200–499 mg/dL as high, and 500 mg/dL or above as severe hypertriglyceridemia.
Do I need to fast for a cholesterol test?
Not always. Nonfasting lipid testing is acceptable for many routine assessments. Fasting testing may be requested when triglycerides are elevated, severe hypertriglyceridemia is suspected, or according to laboratory or clinical protocols.
Can stress increase cholesterol?
Chronic stress may indirectly influence lipid concentrations through hormonal, metabolic, behavioral, dietary, and lifestyle mechanisms, but an isolated high cholesterol result should not automatically be attributed to stress.
Can hypothyroidism cause high cholesterol?
Yes. Hypothyroidism can reduce LDL clearance and is a well-recognized secondary cause of elevated LDL cholesterol.
Can diabetes increase triglycerides?
Yes. Poor glycemic control and insulin resistance may produce significant hypertriglyceridemia and low HDL cholesterol.
What is non-HDL cholesterol?
Non-HDL cholesterol is calculated by subtracting HDL cholesterol from total cholesterol. It represents cholesterol carried in potentially atherogenic particles.
When is calculated LDL unreliable?
Calculated LDL may become unreliable when triglycerides are markedly elevated or when the calculation is used outside the conditions in which it was validated.
36. References and Authoritative Sources
- MedlinePlus. Cholesterol Levels: What You Need to Know .
- MedlinePlus Medical Test. Cholesterol Levels .
- MedlinePlus Medical Test. Triglycerides Test .
- MedlinePlus Medical Encyclopedia. Lipid Profile Test .
- Centers for Disease Control and Prevention. About Cholesterol .
- American Heart Association. About Cholesterol .
Evidence Note: Lipid interpretation is continuously evolving. Reference intervals, cardiovascular-risk categories, LDL treatment thresholds, and recommendations for ApoB, non-HDL cholesterol, and lipoprotein(a) may differ between guidelines and patient groups. Laboratory professionals should use current national or international guidelines together with validated laboratory procedures.
37. Conclusion
The lipid profile is one of the most important laboratory tools for assessing cardiovascular risk. Its interpretation requires more than determining whether total cholesterol is high.
LDL cholesterol remains a central marker of atherogenic risk, while triglycerides, HDL cholesterol, and non-HDL cholesterol provide complementary information about lipid metabolism and cardiovascular risk.
Laboratory professionals must understand specimen requirements, fasting status, LDL calculation limitations, analytical methodology, interference, calibration, and internal quality control before validating patient results.
Clinical interpretation should integrate the lipid profile with age, blood pressure, diabetes, smoking status, kidney and thyroid function, family history, medications, previous cardiovascular disease, and other relevant laboratory and clinical findings.
Medical Disclaimer: This article is intended for educational and laboratory-training purposes only. It does not replace individual medical assessment, diagnosis, treatment, local laboratory procedures, manufacturer instructions, institutional policies, or specialist consultation. Laboratory reference ranges and clinical decision limits may vary according to the analytical method, patient population, laboratory, and current clinical guidelines.
Prepared for: MedLab Academy Category: Clinical Chemistry / Cardiovascular Laboratory Medicine Last Updated: August 20, 2026